Regeneron Pharmaceuticals, Inc. (REGN) financial statements (2021 and earlier)

Company profile

Business Address 777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY 10591
State of Incorp. NY
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,5873,2142,8101,4101,0391,045900
Cash and cash equivalents2,1941,6181,468813535809649
Short-term investments1,3931,5971,342597503236252
Receivables3,1122,3611,9501,7321,4361,306739
Inventory, net of allowances, customer advances and progress billings1,9171,4161,151726399239129
Inventory1,9171,4161,151726399239129
Deferred tax assets    49
Other undisclosed current assets1,164699536467306326350
Total current assets:9,7797,6896,4484,3353,1802,9152,167
Noncurrent Assets
Finance lease, right-of-use asset646 
Property, plant and equipment 2,8902,5762,3592,0831,594974
Long-term investments and receivables3,1363,2571,7551,486864632460
Long-term investments3,1363,2571,7551,486864632460
Deferred income tax assets859824
Other noncurrent assets168145127782063
Deferred tax assets, net 506825462267
Other undisclosed noncurrent assets2,576 829    
Total noncurrent assets:7,3847,1165,2874,4293,7932,6941,704
TOTAL ASSETS:17,16314,80511,7358,7646,9735,6093,872
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,5221,087772815879644484
Accounts payable476 218178135141 
Accrued liabilities33030116512910486 
Employee-related liabilities46634426219215313393
Taxes payable2049210236  
Other undisclosed accounts payable and accrued liabilities231392107315252284391
Deferred revenue 592
Debt    127  
Deferred revenue and credits32023215374
Contract with customer, liability453
Other liabilities122  031496
Other undisclosed current liabilities1,053418218    
Total current liabilities:2,6972,0971,4431,1351,241811655
Noncurrent Liabilities
Long-term debt and lease obligation2,696714    147
Long-term debt, excluding current maturities1,979     147
Finance lease, liability717714
Liabilities, other than long-term debt 905826781931780217
Deferred revenue and credits629831665176
Deferred revenue 619
Contract with customer, liability464
Other liabilities 28636215210011641
Other undisclosed noncurrent liabilities745 709703352363311
Total noncurrent liabilities:3,4411,6191,5341,4851,2831,143675
Total liabilities:6,1383,7162,9772,6202,5241,9541,330
Stockholders' equity
Stockholders' equity attributable to parent, including:11,02511,0908,7576,1444,4493,6552,542
Treasury stock, value(6,613)(740)(396)(316)(316)(306)170
Additional paid in capital6,7164,4293,9123,5133,0303,1002,404
Accumulated other comprehensive income (loss)2921(12)1(13)952
Retained earnings10,8937,3805,2542,9471,748853255
Other undisclosed stockholders' equity attributable to parent000000(339)
Total stockholders' equity:11,02511,0908,7576,1444,4493,6552,542
TOTAL LIABILITIES AND EQUITY:17,16314,80511,7358,7646,9735,6093,872

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues8,4977,8636,7115,8724,8604,1042,820
Revenue, net4,9344,1163,5232,324
Cost of revenue(840)(768)(434)(397)(300)(393)(205)
Cost of goods and services sold(39)(74) (203)(209)(252)(135)
Gross profit:7,6587,0966,2775,4754,5613,7112,615
Operating expenses(4,081)(4,886)(3,742)(3,396)(3,230)(2,459)(1,776)
Other operating income, net280      
Other undisclosed operating loss(280)      
Operating income:3,5772,2102,5342,0801,3311,252838
Nonoperating income (expense)23421919(1)(1)(27)(63)
Other nonoperating income2912504724668
Interest and debt expense(57)(30)(28)  (19)(71)
Other undisclosed income from continuing operations before equity method investments, income taxes573028  1971
Income from continuing operations before income taxes:3,8102,4292,5542,0791,3301,225776
Income tax expense(297)(313)(109)(880)(434)(589)(428)
Net income available to common stockholders, basic:3,5132,1162,4441,199896636348
Interest on convertible debt    0  
Net income available to common stockholders, diluted:3,5132,1162,4441,199896636348

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income:3,5132,1162,4441,199896636348
Other comprehensive income (loss)  (6)13(3)(25) 
Comprehensive income:3,5132,1162,4381,212892611348
Other undisclosed comprehensive income (loss), net of tax, attributable to parent833  (18)(19)53
Comprehensive income, net of tax, attributable to parent:3,5212,1492,4381,212874592402

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: